A Stress Inducible Protein Sestrin2 in Heart Failure
心力衰竭中的应激诱导蛋白 Sestrin2
基本信息
- 批准号:10616476
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AMP-activated protein kinase kinaseAddressAdultAdverse effectsAgingAgonistAntioxidantsBasic ScienceBindingCardiacCardiac MyocytesCaringCause of DeathChronic Obstructive Pulmonary DiseaseClinicalCompensationComplexCongestive Heart FailureCoronaryDataDependovirusDevelopmentDevicesDiabetes MellitusDiagnosisFRAP1 geneGlucoseGoalsHealthcare SystemsHeartHeart HypertrophyHeart failureHomeostasisHospitalizationHypertensionHypertrophyImpairmentInflammatoryKnock-outKnockout MiceLaboratoriesLeft Ventricular HypertrophyMediatingMediatorMedical centerMetabolicMetabolismMicrovascular DysfunctionMolecularMusObesityOutcome StudyPathologicPatientsPharmaceutical PreparationsPhysiologicalPlayPopulationPre-Clinical ModelPrevalencePreventionPromoter RegionsProteinsProviderPublishingRegulationReportingResearchResourcesResponse ElementsRestRisk FactorsRoleScaffolding ProteinSignal PathwaySignal TransductionSirolimusStressSymptomsTestingTetanus Helper PeptideTimeTransgenic MiceTranslational ResearchTreatment FailureVentricular RemodelingVeteransWorkage relatedantagonistcomorbiditycostdisabilityexperimental studyfatty acid metabolismheart functionhypertensiveimprovedmilitary veterannew therapeutic targetnovelolder patientoverexpressionpharmacologicpressurepreventprovider networksresponsesensorsynergismtranscription factor
项目摘要
Heart failure is an increasingly prevalent problem and particularly so amongst an aging Veterans
population. From a clinical standpoint, the prevalence of comorbid conditions such as obesity, diabetes,
COPD (chronic obstructive pulmonary disease), aging and hypertension in these patients has led to the
inflammatory hypothesis where heart failure is also associated with coronary microvascular dysfunction.
Nevertheless, the causal importance of maladaptive substrate metabolism and impaired coronary flow
regulation in the development of the heart failure remain unclear. The work described in this proposal
combines experiments at the basic and translational research level to address the critical need of our
veterans for novel and effective heart failure therapies. The long-term goal of our research is to
understand the molecular mechanisms that underlie the role of Sestrin2 (Sesn2), a stress inducible
protein, in mediating progression from compensated left ventricular hypertrophy to decompensated
hypertrophy and maladaptive ventricular remodeling in heart failure. We have demonstrated that Sesn2 is
a mediator of physiologic and pathologic cardiac hypertrophy and are now seeking to define the
underlying molecular mechanisms. Sesn2 knockout (Sesn2 KO) mice display normal cardiac function at
rest compared to wild type (WT) littermates but are vulnerable with pathologic hypertrophy in response to
pressure overload. Furthermore, recently published data from our lab show that Sesn2 serves as an age-
related protein that modulates AMPK, a cardiac energy sensor, to maintain metabolic homeostasis under
stress conditions. Aging related heart failure could be due to impaired Sesn2-AMPK signaling cascade
occurring in synergy with the adverse effects of hypertension. Thus, our central hypothesis is that Sesn2
serves as a scaffold protein that plays a key role in hypertension induced heart failure in aging. Aim 1: To
determine the upstream signaling pathways that control cardiac Sesn2 expression, and the mechanisms
by which Sesn2-mediated AMPK signaling inhibits development of hypertension-induced heart failure in
aging. Aim 2: To determine the role of Sesn2-mTORC1 complex in the cardiac response to hypertension
and aging. Our long-term objective is to improve the care of Veterans with heart failure by developing a
better understanding of the mechanisms leading to heart failure and identifying novel targeted treatments
that can prevent or reverse hypertensive heart failure.
心脏衰竭是一个越来越普遍的问题,尤其是在老年退伍军人中
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ji Li其他文献
Ji Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ji Li', 18)}}的其他基金
A Stress Inducible Protein Sestrin2 in Heart Failure
心力衰竭中的应激诱导蛋白 Sestrin2
- 批准号:
10363811 - 财政年份:2022
- 资助金额:
-- - 项目类别:
A Stress Inducible Protein Sestrin2 in Heart Failure
心力衰竭中的应激诱导蛋白 Sestrin2
- 批准号:
11002402 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Activated Protein C and Cardiac Inflammatory Response
活化蛋白 C 与心脏炎症反应
- 批准号:
10393231 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Activated Protein C and Cardiac Inflammatory Response
活化蛋白 C 与心脏炎症反应
- 批准号:
10004784 - 财政年份:2018
- 资助金额:
-- - 项目类别:
AMPK-SIRT1 Signaling in the Adaptive Metabolic Response
适应性代谢反应中的 AMPK-SIRT1 信号传导
- 批准号:
9114282 - 财政年份:2015
- 资助金额:
-- - 项目类别:
AMPK-SIRT1 Signaling in the Adaptive Metabolic Response
适应性代谢反应中的 AMPK-SIRT1 信号传导
- 批准号:
9243202 - 财政年份:2015
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant